Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02960113 · ClinicalTrials.gov registry record · Phase 4
Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section
A Phase 4 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 4
- Development phase
- 240
- Enrollment target
NCT02960113 is a Phase 4 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 240 participants.
The verdict
NCT02960113, a Phase 4 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effectiveness of reducing intra-cesarean section nausea and vomiting with regional anesthesia in subjects who will receive scopolamine patch with acupressure point P6 stimulation versus subjects that receive just scopolamine patch versus subjects that receive just acupressure point P6 stimulation.
Interventions
- DRUG scopolamine patch
- DEVICE acupressure point P6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2016-05 |
| Est. Completion | 2021-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02960113
The ClinicalTrials.gov registry entry for NCT02960113 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which scopolamine patch is the first listed.
NCT02960113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02960113 about?
NCT02960113 is a clinical study titled "Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section". The purpose of this study is to compare the effectiveness of reducing intra-cesarean section nausea and vomiting with regional anesthesia in subjects who will receive scopolamine patch with acupressure point P6 stimulation versus subjects that receive just scopolamine patch versus subjects that rece...
What is the current status of trial NCT02960113?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 240 participants. The study started on 2016-05. Estimated completion is 2021-09.
What interventions are being tested in trial NCT02960113?
The interventions under investigation include: scopolamine patch (DRUG), acupressure point P6 (DEVICE).
Who is sponsoring clinical trial NCT02960113?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.